Search - tctmd.com

Displaying 1 - 20 of 68

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

Caitlin E. Cox

December 01, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Daily News

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

L.A. McKeown

October 15, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Todd Neale

March 15, 2024

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Daily News

Wintertime Brings Increased IHCA Risk, US Data Show

Caitlin E. Cox

June 26, 2023

News Daily News

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Caitlin E. Cox

June 16, 2023

News Daily News

Breast Cancer Deaths Lower With Statin Therapy, Taiwanese Data Hint

Caitlin E. Cox

April 26, 2023

News Daily News

PREVENT CLOT Supports Aspirin for VTE Prevention in Trauma Fractures

L.A. McKeown

January 18, 2023

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2025

September 2025 Dispatch for the CV Team

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

September 2024 Dispatch for the CV Team

August 2024 Dispatch for the CV Team

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

May 2024 Dispatch for the CV Team

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

Wintertime Brings Increased IHCA Risk, US Data Show

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Breast Cancer Deaths Lower With Statin Therapy, Taiwanese Data Hint

PREVENT CLOT Supports Aspirin for VTE Prevention in Trauma Fractures

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

More Evidence Links Breast Arterial Calcification and CVD Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content